SEC Filing Summary for AVITA Medical, Inc.

This filing details stock transactions by Robert McNamara, a director at AVITA Medical, Inc. On January 20, 2026, Mr. McNamara was granted 22,214 shares of Common Stock and 16,133 stock options. The Common Stock grant is subject to time-based vesting over 12 months, with vesting criteria detailed in footnote F1. The stock options, with an exercise price of $3.77, were also granted on January 20, 2026, and are subject to stockholder approval, which was obtained on June 3, 2026. The options have an exercise date of January 20, 2027, and an expiration date of January 20, 2036. Post-transaction, Mr. McNamara holds 108,985 shares of Common Stock, including unvested RSUs as noted in footnote F2. The filing was signed on June 4, 2026, reflecting the reporting period of June 3, 2026.